
Curomac Pharmaceutical Private Limited
About Curomac Pharmaceutical Private Limited
Data last updated:
Curomac Pharmaceutical Private Limited is a private limited company based in Dewas, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 January 2024.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U47721MP2024PTC069353.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Narendra Singh Thakur and Nagesh Patil.
Its last annual general meeting (AGM) was held on 31 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dewas, Madhya Pradesh.
Company details
Contact details
Curomac Pharmaceutical Private Limited's registered office is in Dewas, Madhya Pradesh.
- Registered AddressC/Onarendra Singh Thakur, 57 – B Avantika Nagar Maksi, Dewas, Madhya Pradesh, India – 455001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Curomac Pharmaceutical Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Curomac Pharmaceutical Private Limited, buy the company report.
Board of directors of Curomac Pharmaceutical Private Limited
Curomac Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Singh Thakur | Director | 12 Jan 2024 | 2 Years 9 Months | Current |
| Nagesh Patil | Director | 12 Jan 2024 | 2 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Curomac Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curomac Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Curomac Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curomac Pharmaceutical Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Nagesh Patil was appointed as Director on 12 Jan 2024.
Frequently asked questions
Curomac Pharmaceutical is an active private limited company based in Dewas, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 January 2024 (2+ years old) and is registered under CIN U47721MP2024PTC069353.
Curomac Pharmaceutical has 2 current directors:
- Narendra Singh Thakur - Director
- Nagesh Patil - Director
The latest financial statements of Curomac Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 December 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Curomac Pharmaceutical is U47721MP2024PTC069353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curomac Pharmaceutical was incorporated on 12 January 2024, making it 2+ years old. It is registered with the Registrar of Companies, Gwalior.
Nagesh Patil was appointed as Director on 12 Jan 2024. Narendra Singh Thakur was appointed as Director on 12 Jan 2024.
The registered office of Curomac Pharmaceutical is at COnarendra Singh Thakur, 57 – B Avantika Nagar Maksi, Dewas, Madhya Pradesh, India – 455001.
Curomac Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Curomac Pharmaceutical can be reached at its registered office: COnarendra Singh Thakur, 57 – B Avantika Nagar Maksi, Dewas, Madhya Pradesh, India – 455001.
Curomac Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.

